Capital Advisory Group Advisory Services’s Ultragenyx Pharmaceutical RARE Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-150	Closed	-$14K	–	422
2021 Q3	$14K	Hold	150	–	–	0.01%	368
2021 Q2	$14K	Hold	150	–	–	0.01%	367
2021 Q1	$17K	Hold	150	–	–	0.01%	328
2020 Q4	$21K	Sell	150 -150	-50%	-$17.8K	0.01%	310
2020 Q3	$25K	Hold	300	–	–	0.01%	243
2020 Q2	$23K	Hold	300	–	–	0.01%	244
2020 Q1	$13K	Buy	+300	New	+$15.6K	0.02%	206
2019 Q4	–	Sell	-300	Closed	-$13K	–	364
2019 Q3	$13K	Hold	300	–	–	0.01%	254
2019 Q2	$19K	Hold	300	–	–	0.01%	226
2019 Q1	$21K	Buy	+300	New	+$17.1K	0.02%	206

Other funds holding RARE

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return